Advertise
NEWSLETTER
Alterity presents new analy...
Rafael Holdings secures MIT...
4Moving Biotech granted FDA...
Antag Therapeutics to prese...
Springfield Wellness Center...
Alterity presents new analy...
Rafael Holdings secures MIT...
4Moving Biotech granted FDA...
Antag Therapeutics to prese...
Springfield Wellness Center...
Intervention
Singapore-based Gero is the brainchild of Peter Fedichev and are raising $10 million for Longevity drug discovery and indication expansion

Applying theoretical physics to Longevity drug discovery

Epigenetic aging clock DeepMAge has 3-year error margin and could be the most accurate DNA methylation clock to date.

Deep Longevity reveals highly-accurate aging clock

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases.

Jinfiniti’s Startup Showcase success drives collaboration

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases. Augusta

Margaretta Colangelo

Margaretta Colangelo on Longevity2020

Deep Longevity continues to build their life-extension ecosystem with a new structured course on Longevity medicine.

Bridging the gap between Longevity science and clinicians

Dr David Karow

The rise of precision diagnostics and therapeutics

We speak to Dr David Karow about precision medicine and how Health Nucleus is putting the work of Human Longevity into clinical practice.

Health Nucleus: precision medicine for Longevity

Start the clock to stop the clock – centralised data will aid Longevity research with Longenesis and Deep Longevity.

Deep Longevity and Longenesis collaborate to clock aging

A new, highly-detailed cellular and molecular map of the human heart could guide personalised treatments.

Move over, cartography – this is heartography

NetraMark CEO

Using small data to target Alzheimer’s

COVIDomic is an open access tool to stratify risk and severity from multimodal data sets ,including multi-omics data.

Insilico teams-up with Intel to identify disease progression risk

Machine learning unlocks the complexities of multimorbidity

Machine learning unlocks the complexities of multimorbidity

GlobalData says AI holds significant promise for biopharmaceutical companies to expedite the drug repurposing process.

GlobalData finds AI accelerates drug repurposing

Bridging the gap: artificial to biological neuron interfacing

PAI Health to support All-Party Parliamentary Group For Longevity in its quest to extend life expectancy and minimise health inequality.

Partnership demonstrates government Longevity intervention

Microbiome clock has the guts to tell your age

In our Longevity from Singularity conference we seek to address whether technology developments may one day lead us to a form of non-corporeal immortality.

Longevity and the Singularity

Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged by Longevity.Technology

Longevity2020: Day 3 recap

Dr Richard Siow talks COVID-19, its implications for Longevity, and how AI can play a role

AI, COVID-19 and aging: this time it’s personal

Kintell

Meet the Startup: Kintell’s take on Alexa Skills

New socially assistive robot is vital step in healthspan improvement

New socially assistive robot is vital step in healthspan improvement

Using smart devices for non-invasive monitoring is set to become one of the biggest platforms for AI and digital intervention

AI life saver as speakers and smart phones trained to detect cardiac arrests

Scientists have successfully trained a tiny robotic catheter to navigate to a leaky heart valve using artificial intelligence and an on-board camera.

World and Longevity first as self-driving robot fixes leak in failing heart

Harvard graduate designs AI for TB resistance – and people will live longer as a result

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form